Bentley Miami Sparks Important Discussion On Novel Cancer Therapies By Leading Physician Scientist Dr. Guenther Koehne
Miami, FL – October 17, 2019 – Bentley Miami accelerated an important discussion on novel cancer therapies on Thursday, October 17, when they hosted internationally recognized physician scientist, Dr. Guenther Koehne, for an in-depth discussion entitled, “Chemotherapy or Immunotherapy: That is the Question.”
Dr. Koehne, the Deputy Director of Miami Cancer Institute, Chief of Blood & Marrow Transplantation and Hematologic Oncology, spoke to the rapid development of novel immunotherapeutic approaches and their integration into current treatment plans. He emphasized the development of targeted therapeutics such as checkpoint inhibitors and CAR T Cells as non-chemotherapeutic treatment options. Held at the striking Bentley Miami showroom, guests were also treated to a lively mix of cocktails and hors d’oeuvres, and a special preview of the new 2020 Bentley GT and GTC. A curated selection of dazzling Bentley supercars such as the Bentley Bentayga SUV and the Bentley Mulsanne WO Edition by Mulliner made for a spectacular backdrop.
The reception served to turbo-charge the upcoming 2019 Light the Night Campaign, which Dr. Koehne is spearheading as Chairman of The Leukemia & Lymphoma Society (LLS)’s annual walk in downtown Miami. This year’s Light the Night event takes place November 2 at Bayfront Park in Downtown Miami when more than 5,000 people, including corporate and family teams who have been touched by cancer, will gather together to walk in an emotional and uplifting evening that aims to shine light on one of life’s darkest moments.
“As an oncologist who every day gives witness to the devastating effect cancer has on patients and caregivers, I want to especially thank and acknowledge Bentley Miami General Manager Mike Rodriguez for getting behind this important cause that is making a difference in the lives of people with cancer,” said Dr. Koehne.
“We remain truly grateful to Bentley Miami for hosting this lovely event and for giving us the platform to put the campaign in overdrive as we countdown to LLS’s most important fundraiser, Light the Night, on November 2,” said DeAnn Hazey, Executive Director of the South Florida Leukemia & Lymphoma Society.
Among the distinguished guests in attendance were Mike Rodriguez, Dr. Arturo Fridman, Ben Mollere, Bo and Liz Boulenger, Bernard Lackner, Stefan Zachar, Sandra and Randy Fiorenza, Maria Maloof, Lauren Harrison, Manny Gonzales, Susana Moro, Marta Yee, Robert Vinas, Lani Kahn Drody, Susan Kahn, Juan Hinestrosa, Tony Perez, Terry Cifuentes, Kristin Podack, and Mike and Jan Patty among others.
For more information on the Light the Night campaign, sponsorship information or to participate in a corporate or family team please contact: Hebe Occupati at Hebe.Occupati@lls.org.
About LLS A 501 charitable organization, LLS was founded in 1949 and serves as the world’s largest voluntary health organization dedicated to fighting blood cancer. For more than 70 years, LLS has invested more than $1.2 billion to accelerate the development of new cancer therapies and save lives. LLS brings hope instead of despair by working to ensure access to treatments for all blood cancer patients. The nonprofit brings communities together to celebrate those who are fighting the disease and to honor those who have been lost. LLS identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies.